64 results
8-K
EX-10.1
u8nvo mycy
28 Mar 24
Entry into a Material Definitive Agreement
7:55am
8-K
EX-10.2
meow5b8d
28 Mar 24
Entry into a Material Definitive Agreement
7:55am
8-K
EX-10.1
flkc vv3gto
5 Sep 23
Xilio Therapeutics Announces Promotion of Katarina Luptakova, M.D., to Chief Medical Officer and Scott Coleman, Ph.D., to Chief Development Officer
8:35am